Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease

Mami Kikuchi, Mariko Ueno, Yoshiharu Itoh, Wataru Suda, Masahira Hattori

    Research output: Contribution to journalArticle

    18 Citations (Scopus)

    Abstract

    Background: In patients with chronic kidney disease (CKD), many metabolites of gut microbiota retain in the body as uremic toxins (UTs). However, the kinds of bacteria producing UTs are rarely discussed. Methods: We analyzed UT production and the composition of gut microbiota in CKD rats and cecectomized rats. AST-120, a spherical carbon adsorbent, was administrated to evaluate how the precursors of UT affect gut microbiota. Serum and urine levels of UTs were quantified by liquid chromatography/electrospray ionization-tandem mass spectrometry. Gut microbiota were analyzed using 454-pyrosequencing of the 16S rRNA gene. Operational taxonomic unit (OTU) clustering and UniFrac analysis were performed to compare gut microbiota among the groups. Results: Serum and urine levels of indoxyl sulfate and phenyl sulfate were higher in CKD versus control rats (p < 0.05). AST-120 administration decreased UT production (p < 0.01) and changed overall gut microbiota composition in CKD rats. UT urinary excretion and gut microbiota composition changed in cecectomized rats, with the relative abundance of Clostridia- and Bacteroidia-affiliated species being significantly reduced (p < 0.01). We identified candidate indole- and phenol-producing intestinal microbiota, 3 Clostridia, and 2 Bacteroidia. These OTUs have a tryptophanase/tyrosine phenol-lyase gene in the closest sequenced genome out of the OTUs declined following cecectomy. Conclusion: Our data suggest that UT production is correlated with a subset of indigenous gut microbiota. However, UT may be induced by other non-symbiotic microbiota that are influenced by factors other than microbiota populations. The relationship between specific microbiota and UTs in patients requires further clarification.

    Original languageEnglish
    JournalNephron
    DOIs
    Publication statusAccepted/In press - 2016 Oct 5

    Fingerprint

    Chronic Renal Insufficiency
    Microbiota
    Clostridium
    Tyrosine Phenol-Lyase
    Tryptophanase
    Indican
    Urine
    Gastrointestinal Microbiome
    Electrospray Ionization Mass Spectrometry
    Tandem Mass Spectrometry
    Phenol
    Serum
    rRNA Genes
    Liquid Chromatography
    Sulfates
    Cluster Analysis
    Carbon
    Genome
    Bacteria
    Population

    Keywords

    • 16S rRNA
    • AST-120
    • Chronic kidney disease
    • Gut microbiota
    • Pyrosequencing
    • Uremic toxin

    ASJC Scopus subject areas

    • Physiology
    • Nephrology
    • Urology
    • Physiology (medical)

    Cite this

    Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease. / Kikuchi, Mami; Ueno, Mariko; Itoh, Yoshiharu; Suda, Wataru; Hattori, Masahira.

    In: Nephron, 05.10.2016.

    Research output: Contribution to journalArticle

    Kikuchi, Mami ; Ueno, Mariko ; Itoh, Yoshiharu ; Suda, Wataru ; Hattori, Masahira. / Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease. In: Nephron. 2016.
    @article{eb22f5c2d6e841768bb84c60aab31646,
    title = "Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease",
    abstract = "Background: In patients with chronic kidney disease (CKD), many metabolites of gut microbiota retain in the body as uremic toxins (UTs). However, the kinds of bacteria producing UTs are rarely discussed. Methods: We analyzed UT production and the composition of gut microbiota in CKD rats and cecectomized rats. AST-120, a spherical carbon adsorbent, was administrated to evaluate how the precursors of UT affect gut microbiota. Serum and urine levels of UTs were quantified by liquid chromatography/electrospray ionization-tandem mass spectrometry. Gut microbiota were analyzed using 454-pyrosequencing of the 16S rRNA gene. Operational taxonomic unit (OTU) clustering and UniFrac analysis were performed to compare gut microbiota among the groups. Results: Serum and urine levels of indoxyl sulfate and phenyl sulfate were higher in CKD versus control rats (p < 0.05). AST-120 administration decreased UT production (p < 0.01) and changed overall gut microbiota composition in CKD rats. UT urinary excretion and gut microbiota composition changed in cecectomized rats, with the relative abundance of Clostridia- and Bacteroidia-affiliated species being significantly reduced (p < 0.01). We identified candidate indole- and phenol-producing intestinal microbiota, 3 Clostridia, and 2 Bacteroidia. These OTUs have a tryptophanase/tyrosine phenol-lyase gene in the closest sequenced genome out of the OTUs declined following cecectomy. Conclusion: Our data suggest that UT production is correlated with a subset of indigenous gut microbiota. However, UT may be induced by other non-symbiotic microbiota that are influenced by factors other than microbiota populations. The relationship between specific microbiota and UTs in patients requires further clarification.",
    keywords = "16S rRNA, AST-120, Chronic kidney disease, Gut microbiota, Pyrosequencing, Uremic toxin",
    author = "Mami Kikuchi and Mariko Ueno and Yoshiharu Itoh and Wataru Suda and Masahira Hattori",
    year = "2016",
    month = "10",
    day = "5",
    doi = "10.1159/000450619",
    language = "English",
    journal = "Experimental Nephrology",
    issn = "0028-2766",
    publisher = "S. Karger AG",

    }

    TY - JOUR

    T1 - Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease

    AU - Kikuchi, Mami

    AU - Ueno, Mariko

    AU - Itoh, Yoshiharu

    AU - Suda, Wataru

    AU - Hattori, Masahira

    PY - 2016/10/5

    Y1 - 2016/10/5

    N2 - Background: In patients with chronic kidney disease (CKD), many metabolites of gut microbiota retain in the body as uremic toxins (UTs). However, the kinds of bacteria producing UTs are rarely discussed. Methods: We analyzed UT production and the composition of gut microbiota in CKD rats and cecectomized rats. AST-120, a spherical carbon adsorbent, was administrated to evaluate how the precursors of UT affect gut microbiota. Serum and urine levels of UTs were quantified by liquid chromatography/electrospray ionization-tandem mass spectrometry. Gut microbiota were analyzed using 454-pyrosequencing of the 16S rRNA gene. Operational taxonomic unit (OTU) clustering and UniFrac analysis were performed to compare gut microbiota among the groups. Results: Serum and urine levels of indoxyl sulfate and phenyl sulfate were higher in CKD versus control rats (p < 0.05). AST-120 administration decreased UT production (p < 0.01) and changed overall gut microbiota composition in CKD rats. UT urinary excretion and gut microbiota composition changed in cecectomized rats, with the relative abundance of Clostridia- and Bacteroidia-affiliated species being significantly reduced (p < 0.01). We identified candidate indole- and phenol-producing intestinal microbiota, 3 Clostridia, and 2 Bacteroidia. These OTUs have a tryptophanase/tyrosine phenol-lyase gene in the closest sequenced genome out of the OTUs declined following cecectomy. Conclusion: Our data suggest that UT production is correlated with a subset of indigenous gut microbiota. However, UT may be induced by other non-symbiotic microbiota that are influenced by factors other than microbiota populations. The relationship between specific microbiota and UTs in patients requires further clarification.

    AB - Background: In patients with chronic kidney disease (CKD), many metabolites of gut microbiota retain in the body as uremic toxins (UTs). However, the kinds of bacteria producing UTs are rarely discussed. Methods: We analyzed UT production and the composition of gut microbiota in CKD rats and cecectomized rats. AST-120, a spherical carbon adsorbent, was administrated to evaluate how the precursors of UT affect gut microbiota. Serum and urine levels of UTs were quantified by liquid chromatography/electrospray ionization-tandem mass spectrometry. Gut microbiota were analyzed using 454-pyrosequencing of the 16S rRNA gene. Operational taxonomic unit (OTU) clustering and UniFrac analysis were performed to compare gut microbiota among the groups. Results: Serum and urine levels of indoxyl sulfate and phenyl sulfate were higher in CKD versus control rats (p < 0.05). AST-120 administration decreased UT production (p < 0.01) and changed overall gut microbiota composition in CKD rats. UT urinary excretion and gut microbiota composition changed in cecectomized rats, with the relative abundance of Clostridia- and Bacteroidia-affiliated species being significantly reduced (p < 0.01). We identified candidate indole- and phenol-producing intestinal microbiota, 3 Clostridia, and 2 Bacteroidia. These OTUs have a tryptophanase/tyrosine phenol-lyase gene in the closest sequenced genome out of the OTUs declined following cecectomy. Conclusion: Our data suggest that UT production is correlated with a subset of indigenous gut microbiota. However, UT may be induced by other non-symbiotic microbiota that are influenced by factors other than microbiota populations. The relationship between specific microbiota and UTs in patients requires further clarification.

    KW - 16S rRNA

    KW - AST-120

    KW - Chronic kidney disease

    KW - Gut microbiota

    KW - Pyrosequencing

    KW - Uremic toxin

    UR - http://www.scopus.com/inward/record.url?scp=84990226180&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84990226180&partnerID=8YFLogxK

    U2 - 10.1159/000450619

    DO - 10.1159/000450619

    M3 - Article

    C2 - 27701177

    AN - SCOPUS:84990226180

    JO - Experimental Nephrology

    JF - Experimental Nephrology

    SN - 0028-2766

    ER -